Cutting Edge is delighted to annonce its direct commercial representation in Belgium and pursue its European geographical expansion strategy. Our team will bring our ‘concentrate of innovations’ Synthesis intraocular lens platform straight from our Toulouse (France) manufacturing and logistics hub directly to the Belgium end-users. The first Synthesis IOL was first implanted at

Kestrel Ophthalmics (a Cutting Edge company) is delighted to announce its Synthesis preloaded system makes UK debut with consultant ophthalmologist Mr Arun Sachdev & Mr Say Aun Quah at Macclesfield District NHS Hospital.   Cutting Edge SAS builds experienced and dedicated teams to design, prototype and manufacture high-quality Intraocular Lenses. Cutting Edge’ state-of-the-art facility located in

Our UK subsidiary (Kestrel Ophthalmics Ltd – a Cutting Edge company) is launching its eye catching new campaign today.

Cutting Edge is proud to present its Synthesis preloaded IOL system (our Concentrate of Innovations) at the 30th International Congress of German Ophthalmic Surgeons in Nuremberg. For more information regarding our commercial representation in Germany

Kestrel Ophthalmics (a Cutting Edge Company) announced today it launched its new brand identity at the Royal College of Ophthalmologists congress in Liverpool (UK). Nearly 4,000 ophthalmologists and health care professionals are attenting this year scientific programme, seminars and surgical skills courses organised by the #RCOphth17committee. “Our new brand relaunch represents the natural evolution and transformation of

Cutting Edge begins its commercial operations this month and attend the Polish Ophthalmic Conference today in Krakow. Discover the Inov8 innovative surgical portfolio -our surgical exclusive partner-  

Cutting Edge is proud to announce the opening of its Spanish offices, following successful registration of its newest IOLs, OVDs and retinal liquids & gas portfolios. Commercial operations will start immediately under the leadership of Jordi Rojals (General Manager Cutting Edge Surgical Espana SL). “Jordi is a seasoned executive with more than 25 years expertise in the

February 12, 2018, Montpellier, France. Cutting Edge SAS proudly announced today that our partner has successfully registered Synthesis Preloaded IOLs in the Italian Health’s Ministry Database.

Genesis, the latest addition of the Cutting Edge IOL portfolio, received CE Mark approval. The lens is immediately available to all our loyal customers and partners around the world.